Balance and Proprioception Training Program in Patients With Chronic Ankle Sprains

Sponsor
Ahram Canadian University (Other)
Overall Status
Recruiting
CT.gov ID
NCT05920044
Collaborator
(none)
45
1
2
12.5
3.6

Study Details

Study Description

Brief Summary

To examine the effects of an individualized balance and proprioception training program on pain, function, and the risk of recurrent ankle sprains.

Condition or Disease Intervention/Treatment Phase
  • Other: balance and proprioception training program.
  • Other: Usual care
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
45 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
The Effects of an Individualized Balance and Proprioception Training Program on Pain and Function in Patients With Chronic Ankle Sprains: A Randomized Controlled Trial
Anticipated Study Start Date :
Jun 27, 2023
Anticipated Primary Completion Date :
Jun 27, 2024
Anticipated Study Completion Date :
Jul 12, 2024

Arms and Interventions

Arm Intervention/Treatment
Experimental: Intervention Group:

Participants will receive an eight-week individualized balance and proprioception training program.

Other: balance and proprioception training program.
The program will include exercises focused on improving ankle stability and joint position sense, such as single-leg stance, wobble board, and resistance band exercises. Participants will attend two supervised sessions per week and perform home-based exercises 3-4 times per week. Progression of exercises will be individualized based on participant performance and tolerance.

Active Comparator: Control group

Participants will continue their usual care, including general strength and flexibility exercises.

Other: Usual care
Participants will continue their usual care, including general strength and flexibility exercises. No specific balance and proprioception training will be provided.

Outcome Measures

Primary Outcome Measures

  1. Changes in Pain intensity [Changes in Pain intensity at baseline, 8 weeks, and 16 weeks follow up]

    Pain intensity will be measured using the Numeric Pain Rating Scale (NPRS)

  2. Changes in Functional Ability [Changes in Functional ability at baseline, 8 weeks, and 16 weeks follow up]

    Functional ability will be assessed using the Foot and Ankle Ability Measure (FAAM)

Secondary Outcome Measures

  1. Changes in Balance [Changes in balance at baseline, 8 weeks, and 16 weeks follow up]

    Balance will be assessed using the Star Excursion Balance Test (SEBT)

  2. Changes in Proprioception [Changes in proprioception at baseline, 8 weeks, and 16 weeks follow up]

    Proprioception will be measured using the joint position sense test with an ankle electrogoniometer

  3. Incidence of Recurrent Ankle Sprains [From post-intervention at 8 weeks to the end of the follow-up period at 16 weeks]

    Incidence of recurrent ankle sprains during the follow-up period will be recorded

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 35 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Adults aged 18-55 years

  • History of at least two ankle sprains within the last 12 months

  • Presence of ankle instability symptoms, such as recurrent giving way or chronic pain

Exclusion Criteria:
  • Acute ankle injury within the last six weeks

  • Lower extremity fracture within the last six months

  • Other musculoskeletal or neurological disorders affecting the lower extremity

  • Inability to comply with study requirements

Contacts and Locations

Locations

Site City State Country Postal Code
1 Outpatient clinic of faculty of physical therapy, Ahram Canadian University Al Ḩayy Ath Thāmin Giza Egypt 3221405

Sponsors and Collaborators

  • Ahram Canadian University

Investigators

  • Study Director: Amal Fawzy, Ph.d, Faculty of Physical Therapy, Ahram Canadian University

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Mohamed Magdy ElMeligie, Lecturer of Physical Therapy and Director of Electromyography Lab, Ahram Canadian University
ClinicalTrials.gov Identifier:
NCT05920044
Other Study ID Numbers:
  • 012/Ank-01200021
First Posted:
Jun 27, 2023
Last Update Posted:
Jun 27, 2023
Last Verified:
Jun 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jun 27, 2023